Innovation Pharmaceuticals Inc (IPIX)

[BioHedge]

today is a great example of how hard it is to time a market. This morning we had great news validating a lot of DD and claims made by the company. But we didn't see hardly any price movement. On other, non-news days, we have 15%-20% swings. I like CTIX because to date nothing management has done or any negative data has made me question my very favorable outlook.

As the news builds and people become aware of what CTIX is doing, share value will increase.

As a side note, I'd like to caution some on making apple to oranges comparisons on price per share. I see a lot of comments like, XYZ company is not as far a long as CTIX but is trading for $6/share... the more important metric to look at is market cap or total valuation. those same companies trading at $6/share may only have 10M shares outstanding. CTIX has more than 100M fully diluted.

As CTIX continues to prove it's value, the market cap will climb and I'd be shocked if we weren't in the 1B range with some good news from the Phase I trail. Mr. Market is pretty good at determining winners and looses (not prefect) but if Kevetrin was in Phase III and CTIX only valued at 400M I'd be worried. Big drugs = big paydays. That is why I rarely put big money to work in Phase III trial companies with small market caps (less than 750M).